These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 8023771

  • 1. [Re-examination of the criteria for clinical evaluation on bacterial prostatitis--analysis of the data of the clinical study of temafloxacin].
    Arakawa S, Kamidono S, Hirose T, Kumamoto Y, Suzuki K, Ito Y, Ban Y, Kawada Y, Kumon H, Ohmori H.
    Hinyokika Kiyo; 1994 May; 40(5):455-66. PubMed ID: 8023771
    [Abstract] [Full Text] [Related]

  • 2. [Clinical studies on chronic prostatitis and prostatitis-like syndrome. (3). Clinical re-examination of chronic bacterial prostatitis using the criteria for clinical evaluation].
    Ikeuchi T.
    Hinyokika Kiyo; 1990 May; 36(5):561-8. PubMed ID: 2399857
    [Abstract] [Full Text] [Related]

  • 3. [Clinical studies of tosufloxacin on chronic bacterial prostatitis].
    Ikeuchi T, Kawamura N, Suzuki K, Onodera S, Osada T, Hirano A, Satomi Y, Yoshimura S, Yamamoto Y.
    Hinyokika Kiyo; 1993 Jul; 39(7):673-8. PubMed ID: 8362691
    [Abstract] [Full Text] [Related]

  • 4. Assessment of the UTI criteria for bacterial prostatitis in Japan.
    Arakawa S, Kamidono S.
    Infection; 1992 Jul; 20 Suppl 3():S232-4. PubMed ID: 1337062
    [Abstract] [Full Text] [Related]

  • 5. [Clinical and bacteriological study of sparfloxacin on bacterial prostatitis].
    Suzuki K, Horiba M, Naide Y, Shinoda M, Hibi H.
    Hinyokika Kiyo; 1992 Jan; 38(1):121-8. PubMed ID: 1312292
    [Abstract] [Full Text] [Related]

  • 6. [Proposal of a standard method for clinical evaluation of antimicrobial agents in prostatitis--specifications of patients and criteria for evaluation of clinical efficacy].
    Kamidono S, Arakawa S, Ishigami J, Sasai S, Kumamoto Y, Kawamura N, Ohkoshi M, Suzuki K, Naide Y, Ohkawa M.
    Hinyokika Kiyo; 1989 Mar; 35(3):427-45. PubMed ID: 2735252
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis.
    Magri V, Trinchieri A, Pozzi G, Restelli A, Garlaschi MC, Torresani E, Zirpoli P, Marras E, Perletti G.
    Int J Antimicrob Agents; 2007 May; 29(5):549-56. PubMed ID: 17336504
    [Abstract] [Full Text] [Related]

  • 8. [Clinical studies against chronic prostatitis and prostatitis-like syndrome (2). Evaluation of therapeutic effect].
    Ikeuchi T.
    Hinyokika Kiyo; 1988 Mar; 34(3):453-60. PubMed ID: 2898886
    [Abstract] [Full Text] [Related]

  • 9. Treatment of bacterial prostatitis.
    Schwager EJ.
    Am Fam Physician; 1991 Dec; 44(6):2137-41. PubMed ID: 1746395
    [Abstract] [Full Text] [Related]

  • 10. [Laboratory and clinical study of ofloxacin in the treatment of bacterial prostatitis].
    Suzuki K, Tamai H, Naide Y, Ando K, Moriguchi R.
    Hinyokika Kiyo; 1984 Oct; 30(10):1505-18. PubMed ID: 6596877
    [Abstract] [Full Text] [Related]

  • 11. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J, Profant M, Kostrica R, Waskin H.
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [Abstract] [Full Text] [Related]

  • 12. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA, Mathew CP, Warner JH, Heyd A, Church D.
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [Abstract] [Full Text] [Related]

  • 13. Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis.
    Naber KG, Roscher K, Botto H, Schaefer V.
    Int J Antimicrob Agents; 2008 Aug; 32(2):145-53. PubMed ID: 18571904
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA, Bettis R, Munk ZM, Fleming H, Munn NJ, Riffer E, Bagby B, Giguere G, Collins JJ.
    Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
    [Abstract] [Full Text] [Related]

  • 15. [Clinical study of a new injectable cephem, FK037, for acute bacterial prostatitis].
    Suzuki K, Horiba M, Ishikawa K, Katoh S.
    Hinyokika Kiyo; 1994 Dec; 40(12):1131-7. PubMed ID: 7863869
    [Abstract] [Full Text] [Related]

  • 16. Treatment of chronic bacterial prostatitis with temafloxacin.
    Cox CE, Childs SJ.
    Am J Med; 1991 Dec 30; 91(6A):134S-139S. PubMed ID: 1662884
    [Abstract] [Full Text] [Related]

  • 17. [Clinical efficacy of T-3262, a new quinolone compound, on urinary tract infection in 1988].
    Suzuki K, Nagata Y.
    Hinyokika Kiyo; 1989 Apr 30; 35(4):717-26. PubMed ID: 2735274
    [Abstract] [Full Text] [Related]

  • 18. A proposal of subcategorization of bacterial prostatitis: NIH category I and II diseases can be further subcategorized on analysis by therapeutic and immunological procedures.
    Naide Y, Ishikawa K, Tanaka T, Ando S, Suzuki K, Hoshinaga K.
    Int J Urol; 2006 Jul 30; 13(7):939-46. PubMed ID: 16882059
    [Abstract] [Full Text] [Related]

  • 19. [Etiotropic therapy of chronic bacterial prostatitis].
    Popov SV, Mazo EB.
    Urologiia; 2008 Jul 30; (3):36, 38-41. PubMed ID: 18669346
    [Abstract] [Full Text] [Related]

  • 20. [Comprehensive therapy for chronic bacterial prostatitis: report of 52 cases].
    Zhou DQ, Wen HT, Tan WL.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr 30; 22(4):368-9. PubMed ID: 12390750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.